Singapore markets open in 4 hours 45 minutes

Iovance Biotherapeutics, Inc. (IOVA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.24+0.35 (+3.54%)
At close: 04:00PM EDT
10.14 -0.10 (-0.96%)
After hours: 04:06PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
282,677
259,039
201,727
166,023
99,828
Selling general and administrative
94,477
83,664
60,210
40,849
28,430
Total operating expenses
377,154
342,703
261,937
206,872
128,258
Operating income or loss
-377,154
-342,703
-261,937
-206,872
-128,258
Income before tax
-376,408
-342,252
-259,581
-197,556
-123,580
Income from continuing operations
-376,408
-342,252
-259,581
-197,556
-123,580
Net income
-376,408
-342,252
-259,581
-197,556
-123,580
Net income available to common shareholders
-376,408
-342,252
-259,581
-197,556
-123,580
Basic EPS
-
-2.23
-1.88
-1.59
-1.27
Diluted EPS
-
-2.23
-1.88
-1.59
-1.27
Basic average shares
-
153,406
138,301
124,336
97,277
Diluted average shares
-
153,406
138,301
124,336
97,277
EBITDA
-
-328,723
-260,797
-205,703
-127,302